From DCAT Value Chain Insights (VCI)
Cytovance Biologics, an Oklahoma City, Oklahoma-based biopharmaceutical contract manufacturing company specializing in mammalian and microbial biologics, has appointed Mike O'Mara as senior vice president of manufacturing operations.
Mr. O'Mara has more than 23 years of experience in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell therapy manufacturing processes ranging from preclinical/Phase I through commercial stage. Prior to Cytovance, Mr. O’Mara worked at DynPort Vaccine Corporation as senior director of manufacturing for 2 years. He was also TissueGene's vice president of manufacturing and worked for Lonza Biologics for 18 years in several operations and manufacturing positions.
Mr. O’Mara has been part of numerous technology transfers, operational excellence initiatives, US Food and Drug Administration and regulatory agency audits, growing organizations, and manufacturing expansions/build-outs.
Source: Cytovance Biologics
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription